GlassScriptPhysician profile
Chelsea Callagy
NPI 1902455611
$3,063.91
in general payments reported to CMS, 2019-2025
24 companies · $594 in 2025
The $594 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $934 · 2022: $318 · 2023: $580 · 2024: $639 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,811.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,373.05 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Vectris Surescan |
| Astellas Pharma US INC | $239.81 | 2021 | |
| Averitas Pharma INC. | $208.55 | 2023-2025 | Qutenza |
| Astrazeneca Pharmaceuticals LP | $168.37 | 2021 | |
| Myovant Sciences INC. | $144.23 | 2021 | |
| Vertos Medical, INC. | $137.96 | 2022-2024 | Mild Device Kit |
| Janssen Biotech, INC. | $136.34 | 2021 | |
| Boston Scientific Corporation | $112.61 | 2022 | |
| Dendreon Pharmaceuticals LLC | $77.62 | 2021 | |
| Tersera Therapeutics LLC | $66.80 | 2025 | Prialt |
| Endo Pharmaceuticals INC. | $55.33 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $49.51 | 2025 | |
| Stryker Corporation | $40.69 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $40.33 | 2022-2023 | Belbuca |
| Genzyme Corporation | $30.97 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $28.60 | 2022 | |
| Grt US Holding, INC. | $24.32 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $23.53 | 2021 | |
| Myriad Genetic Laboratories, INC. | $22.76 | 2021 | |
| Clarus Therapeutics INC. | $21.15 | 2021 | |
| Merck Sharp & Dohme LLC | $17.97 | 2021 | |
| Olympus America INC. | $16.56 | 2025 | Itind System |
| Dentsply Ih Ab | $15.59 | 2021 | |
| Antares Pharma, INC. | $11.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chelsea Callagy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.